Literature DB >> 7559585

Mutational analysis of PC1 (SPC3) in PC12 cells. 66-kDa PC1 is fully functional.

Y Zhou1, C Rovere, P Kitabgi, I Lindberg.   

Abstract

The proteinase mPC1, a neuroendocrine member of the mammalian family of subtilisin-like enzymes, has previously been shown to be converted to a carboxyl-terminally truncated 66-kDa form during transport through the secretory pathway. The cleavage site and the function of this carboxyl-terminal truncation event are unknown. We have performed site-directed mutagenesis of two paried basic sites in the mPC1 carboxyl-terminal tail and expressed these constructs in PC12 cells, a rat pheochromocytoma known to lack endogenous PC1. We found that the most likely site for the truncation event was at Arg590-Arg591 since mutation of this site to Lys-His prevented processing of 87-kDa PC1. A PC1 mutant carboxyl-terminally truncated at this site and expressed in PC12 cells was efficiently routed to the secretory pathway and stored in secretory granules, indicating that the carboxyl-terminal extension is not required for sorting of this enzyme. The function of the various PC1 constructs was assessed by analyzing proneurotensin cleavage to various forms. The carboxyl-terminally truncated PC1 mutant was found to perform most of the cleavages of this precursor as well as wild-type PC1; however, the blockade mutant processed proneurotensin much less efficiently. Differences between the site preferences of the various enzymes were noted. Our results support the notion that carboxyl-terminal processing of PC1 serves to regulate PC1 activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559585     DOI: 10.1074/jbc.270.42.24702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The transmembrane domain of the prohormone convertase PC3: a key motif for targeting to the regulated secretory pathway.

Authors:  Hong Lou; Angela M Smith; Leigh C Coates; Niamh X Cawley; Y Peng Loh; Nigel P Birch
Journal:  Mol Cell Endocrinol       Date:  2006-12-16       Impact factor: 4.102

2.  PACE4: a subtilisin-like endoprotease with unique properties.

Authors:  R E Mains; C A Berard; J B Denault; A Zhou; R C Johnson; R Leduc
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  The integrity of the RRGDL sequence of the proprotein convertase PC1 is critical for its zymogen and C-terminal processing and for its cellular trafficking.

Authors:  J Lusson; S Benjannet; J Hamelin; D Savaria; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.

Authors:  Akihiko Ozawa; Juan R Peinado; Iris Lindberg
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

5.  Regulation of neuropeptide processing enzymes by catecholamines in endocrine cells.

Authors:  Michael Helwig; Mirella Vivoli; Lloyd D Fricker; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-05-03       Impact factor: 4.436

6.  Modulation of PC1/3 activity by self-interaction and substrate binding.

Authors:  Akina Hoshino; Dorota Kowalska; François Jean; Claude Lazure; Iris Lindberg
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

7.  Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Authors:  Elias H Blanco; Juan R Peinado; Martín G Martín; Iris Lindberg
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

8.  Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function.

Authors:  Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg
Journal:  Endocrinology       Date:  2014-05-14       Impact factor: 4.736

9.  Hysteretic behavior of proprotein convertase 1/3 (PC1/3).

Authors:  Marcelo Y Icimoto; Nilana M Barros; Juliana C Ferreira; Marcelo F Marcondes; Douglas Andrade; Mauricio F Machado; Maria A Juliano; Wagner A Júdice; Luiz Juliano; Vitor Oliveira
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

10.  Functional consequences of a novel variant of PCSK1.

Authors:  Lindsay A Pickett; Michael Yourshaw; Valeria Albornoz; Zijun Chen; R Sergio Solorzano-Vargas; Stanley F Nelson; Martín G Martín; Iris Lindberg
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.